Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases

The company will develop new medicines to selectively potentiate and expand regulatory T cells.

Circle Pharma Enters into an Agreement with Pfizer to Build Screening Library of Macrocyclic Peptides

Circle Pharma Enters into an Agreement with Pfizer to Build Screening Library of Macrocyclic Peptides

Pfizer will support Circle as the startup uses computational design and synthetic chemistry to build a library of macrocyclic peptides.

Mayo Adds To Its List Of Gut Microbiome Startup Collaborators

Mayo Adds To Its List Of Gut Microbiome Startup Collaborators

The Mayo Institute and Whole Biome are collaborating to decrease rates of preterm birth and labor.